Histone-deacetylase inhibitors produce positive results in the GADD45a-GFP GreenScreen HC assay
- 18 March 2013
- journal article
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 751 (2) , 96-100
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Histone Deacetylase Inhibitors: Overview and PerspectivesMolecular Cancer Research, 2007
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell linesCancer Letters, 2006
- Histone Deacetylase Inhibitors Radiosensitize Human Melanoma Cells by Suppressing DNA Repair ActivityClinical Cancer Research, 2005
- Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitorsProceedings of the National Academy of Sciences, 2005
- Selective Growth Inhibition of Tumor Cells by a Novel Histone Deacetylase Inhibitor, NVP-LAQ824Cancer Research, 2004
- p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-YOncogene, 2003
- Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) α and β messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cellsCancer Letters, 2002
- Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed CellsJNCI: Journal of the National Cancer Institute, 2000
- Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamateBritish Journal of Cancer, 1999